Architect Therapeutics

C-H activation to design and synthesize novel 3D scaffolds

San Diego, United States · Founded 2023 · $120.0M raised

Employees
11–50
Founded
2023
Business Model
B2B
Total Funding
$120.0M
Last Round
$120.0M Series BJan 2024
Rounds
3

About

Architect Therapeutics is a San Diego biopharmaceutical company leveraging C-H bond activation chemistry pioneered by founder Jin-Quan Yu to design novel 3D small molecule drug architectures. The platform integrates covalent and non-covalent drug discovery approaches with proprietary libraries and advanced screening to pursue first- and best-in-class therapies in immunology and oncology.

Summary

Architect Therapeutics is a Biotech company based in San Diego, United States, founded in 2023. It has raised $120.0M in total across 3 rounds, most recently a $120.0M Series B round in Jan 2024. Investors include OrbiMed, ARCH Venture Partners and Frazier Healthcare.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BJan 2024

Sign up to see all 3 rounds

Seed through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Architect Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/architect-therapeutics"><img src="https://indexed.vc/api/badge/company/architect-therapeutics" alt="Architect Therapeutics on Indexed.vc" width="260" height="76" /></a>